ArticlePloS one2024

Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer.

Gee-Chen Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.